Method for treating a disease or condition responsive to opening of C1C-2 channel
AssigneeSucampo AG
InventorRyuji Ueno
Life of this patent
Estimating the term…
Abstract
Disclosed is a method for prophylactic or therapeutic treatment of a condition or disease responsive to opening of ClC-2 channel, which comprises the step of administrating an effective amount of a ClC-2 channel opener to a subject in need of said treatment. According to the invention, a tissue or organ to be transplanted can also be treated with the ClC-2 channel opener.
Claims16
A method for prophylactic or therapeutic treatment of a condition or disease responsive to opening of ClC-2 channel, which comprises the step of administrating an effective amount of a ClC-2 channel opener to a subject in need of said treatment, provided that the condition or disease is not cystic fibrosis.
A method for treating a tissue or organ to be transplanted in a transplantation procedure, which comprises the step of contacting the tissue or the organ with a pharmaceutical composition comprising a ClC-2 channel opener as an active ingredient.
Dependencies are inferred from the claim text.